Dai Ichi Life Insurance Company, LTD Novo Cure LTD Transaction History

Dai Ichi Life Insurance Company, LTD

  • $3.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$40.29 - $82.51 $280,337 - $574,104
6,958 New
6,958 $288,000
Q1 2022

May 13, 2022
SELL
$60.15 - $84.52 $779,423 - $1.1 Million
-12,958 Closed
0 $0
Q3 2021

Nov 04, 2021
BUY
$116.17 - $194.55 $813,190 - $1.36 Million
7,000 Added 117.49%
12,958 $1.51 Million
Q2 2021

Aug 13, 2021
BUY
$130.4 - $225.58 $776,923 - $1.34 Million
5,958 New
5,958 $1.32 Million

Others Institutions Holding NVCR

# of Institutions
263
Shares Held
77M
Call Options Held
1.17M
Put Options Held
318K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.37B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Dai Ichi Life Insurance Company, LTD Portfolio

Follow Dai Ichi Life Insurance Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email